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Abstract
Background: Extensive mononuclear cell infiltration is strongly correlated with liver damage in patients with chronic
hepatitis B virus (CHB) infection. Macrophages and infiltrating monocytes also participate in the development of liver
damage and fibrosis in animal models. However, little is known regarding the immunopathogenic role of peripheral blood
monocytes and intrahepatic macrophages.
Methodology/Principal Findings: The frequencies, phenotypes, and functions of peripheral blood and intrahepatic
monocyte/macrophage subsets were analyzed in 110 HBeAg positive CHB patients, including 32 immune tolerant (IT)
carriers and 78 immune activated (IA) patients. Liver biopsies from 20 IA patients undergoing diagnosis were collected for
immunohistochemical analysis. IA patients displayed significant increases in peripheral blood monocytes and intrahepatic
macrophages as well as CD16
+ subsets, which were closely associated with serum alanine aminotransferase (ALT) levels and
the liver histological activity index (HAI) scores. In addition, the increased CD16
+ monocytes/macrophages expressed higher
levels of the activation marker HLA-DR compared with CD16
2 monocytes/macrophages. Furthermore, peripheral blood
CD16
+ monocytes preferentially released inflammatory cytokines and hold higher potency in inducing the expansion of
Th17 cells. Of note, hepatic neutrophils also positively correlated with HAI scores.
Conclusions: These distinct properties of monocyte/macrophage subpopulations participate in fostering the inflammatory
microenvironment and liver damage in CHB patients and further represent a collaborative scenario among different cell
types contributing to the pathogenesis of HBV-induced liver disease.
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Introduction
Chronic hepatitis B virus (HBV) infection is one of the most
serious public health problems, with approximately 400 million
HBV carriers worldwide, and 1–2 million people succumbing to
HBV-induced liver cirrhosis and hepatocellular carcinoma each
year, especially in China where approximately 22 million people
suffer from chronic hepatitis B (CHB) [1]. HBV itself is non-
cytopathic, but immune-mediated liver damage often occurs in
patients with HBV infection and further contributes to disease
progression [2]. The prevailing understanding has been that the
HBV-specific CD8 T cells mainly contribute to killing virally
infected hepatocytes [3]. Recent studies have shown that non-
specific lymphocytes are significantly infiltrated in livers of CHB
patients, such as dendritic cells (DCs), natural killer cells, Th17
cells and Treg cells, playing distinct roles in modulating the
inflammatory process [4–7]. These findings, therefore, suggest that
multiple types of immune cells may actively participate in HBV-
associated liver pathogenesis [8]. Herein, understanding the
reciprocal linkage between immune cells during chronic HBV
infection is a prerequisite for developing effective treatment
strategies for the disease.
As an important component of innate immunity, monocytes
contribute directly to the immune defense against bacterial,
protozoal, and fungal pathogens through strong activation of
inflammatory cytokine responses [9]. The monocyte-related
inflammatory activation can also be induced by some viral
antigens [10–12]. In addition, cytokines such as IL-17 increased
under inflammatory conditions effectively trigger the activation of
monocytes [6]. Furthermore, different monocyte subsets with
distinct phenotypic and functional characteristics are proposed to
exist: classical CD14
highCD16
2 monocytes representing about
90% of circulating monocytes and the pro-inflammatory CD16
+
monocytes. The latter can be further divided into two minor
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high CD16
+ and CD14
low CD16
+subpopulations [13]. These
CD16
+ monocytes selectively express surface antigens akin to
tissue macrophages and produce higher levels of pro-inflammatory
cytokines (e.g., TNF, IL-1, IL-6) compared to CD14
highCD16
2
monocytes. Increasing evidence shows that the increased CD16
+
monocytes collaborating with CD14
highCD16
2 monocytes play an
important role in shaping the inflammatory environment [14,15].
More recently, elevated CD14
highCD16
+ monocytes were corre-
lated with increased viral loads and decreased CD4
+ T-cell counts
in HIV infection [16]. However, very little is known about
whether the CD16
+ monocytes/macrophages contribute to the
inflammatory environment in the livers of CHB patients.
Th17 cells with potent pro-inflammatory properties have gained
considerable attention [17,18]. Studies in other systems have
found that the production of IL-17 by human Th17 cells critically
depends on both the activation status and the anatomical location
of accessory cells and seems to occur particularly in the presence of
activated antigen-presenting cells such as monocytes or DC [19–
21]. In a previous study, we found that Th17 cells increased with
the severity of liver damage in CHB patients [6]. Notably, these
Th17 cells in the liver spontaneously produced IL-17A. IL-17A
can mobilize, recruit and activate neutrophils, leading to massive
tissue inflammation and the progression of autoimmune disease
and liver disease [22,23]. However, whether monocytes/macro-
phages or their subsets can foster the inflammatory environment in
livers of CHB patients, which further favor the activity of Th17
cells, remains largely unknown.
In the present study, we characterized monocytes/macrophages
with their subsets, as well as neutrophils in CHB patients and
found that these pathogenic cells were increased in their livers.
Furthermore, these highly pathogenic cells may be linked to the
inflammation in the livers of these CHB patients. These findings
will facilitate the understanding of the mechanisms underlying the
pathogenesis of liver damage and of hepatic immune cells during
inflammation.
Methods
Patients
A total of 110 HBV-infected HBeAg positive subjects, including 78
immune activated (IA) patients and 32 immune tolerant (IT) carriers,
were recruited in this study. All patients were diagnosed according to
our previously described criteria [6,7,24]. Briefly, the IT group was
defined as patients with high levels of circulating HBV DNA (.10
6
IU/ml), but normal alanine aminotransferase (ALT) levels (normal
range: ,40 U/L). The IA group included patients with detectable
circulating HBV DNA (.100 IU/ml) and elevated serum ALTlevels
(.40 U/L). None of the subjects with HBV infection included in the
study had received antiviral therapy or immunosuppressive drugs
within 6 months before sampling. Liver biopsies were collected from
20 IA patients,and the degree of hepatic inflammation was graded by
the modified histological activity index (HAI) [25]. Briefly, two
components, Grading (G) and Staging (S), were given in a numerical
value ranged from 0 to 4: Grading was used to describe the intensity
of necro-inflammatory activity, and Staging was a measure of fibrosis
and architectural alteration in chronic hepatitis. Increased numerical
value indicated the more severity of disease. Individuals with co-
infections of HCV, hepatitis D virus, and HIV infections were
excluded from enrollment. The study protocol was approved by
Beijing 302 Hospital Research Ethnics Committee, and written
informed consent was obtained from all participants. Baseline clinical
data are shown in Table 1. For comparison, 38 uninfected healthy
controls (HCs) were age and sex matched to the enrolled patient as
controls.
Flow cytometric analysis
All antibodies were purchased from BD Biosciences (San Jose,
CA, USA) except for phycoerythrin (PE)-conjugated anti-human
IL-17A.
For surface marker staining, fresh heparinized peripheral blood
(100 ml) was labeled with the following monoclonal antibodies:
allophycocyanin (APC)-conjugated anti-human CD14, fluorescein
isothiocyanate (FITC)-conjugated anti-human CD16 and peridin
chlorophyll protein (PerCP)-conjugated HLA-DR. Matched
isotype antibodies were used as negative controls. After incubation
for 30 min at 4uC in the dark, FACS
TM lysing solution (BD
PharMingen) was added to lyse the red blood cells.
For intracellular cytokine staining, fresh heparinized peripheral
blood (200 ml) was incubated in 800 ml RPMI 1640 medium
supplemented with 10% fetal calf serum for 6 h as previously
described [6]. Monensin (0.4 mM, BD PharMingen) was added
during the first hour of incubation. After incubation, the blood was
washed with PBS and stained with APC-conjugated anti-human
CD14, FITC-conjugated anti-human CD16 and PerCP-conjugat-
ed anti-human HLA-DR for 30 min at 4uC in the dark.
Subsequently, the red blood cells were lysed with FACS
TM lysing
solution, and the remaining cells were further permeabilized,
stained with the corresponding intracellular antibody, fixed, and
analyzed using FACSCalibur and FlowJo software (Tristar, USA)
as previously described [14].
Cell isolation
Peripheral blood mononuclear cells (PBMCs) were isolated by
Ficoll–Hypaque (Pharmacia, Uppsala, Sweden) density gradient
centrifugation from heparinized blood. Monocyte counts of these
patients were determined by an automated hematology analyzer
Table 1. Clinical characteristics of the populations enrolled in
the study.
Group HC IT IA
Case 38 32 78
Sex (male/female) 20/18 18/14 40/38
Age (years) 31 (18–42) 30 (18–44) 35 (18–49)
ALT (U/L) 21 (10–37) 27 (13–40) 144 (43–1656) *
HBV DNA (IU/ml) ND 1.866108
(1.776106–2.1986109)
2.36107
(110–2.536109) *
Cases with liver
biopsy
00 2 0
Inflammation Score
G1 0 0 9
G2 0 0 7
G3 0 0 3
G4 0 0 1
Fibrosis Score
S1 0 0 12
S2 0 0 3
S3 0 0 4
S4 0 0 1
Data are shown as median and range. HC: healthy control; IT: immune-tolerant
carriers with HBV infection; IA: immune-active patients with HBV infection. ND:
not determined.
*P,0.05 vs. IT subjects.
doi:10.1371/journal.pone.0017484.t001
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[26].
Liver biopsy specimens were homogenized for isolation of
intrahepatic leukocytes (LILs) according to our previously
described protocols [7], and then LILs were washed in PBS and
resuspended in RPMI 1640 with 10% FCS for direct staining with
the antibodies.
CFSE-based proliferation assay and stimulation
Carboxyfluorescein succinimidyl ester (CFSE)-based prolifera-
tion assays were performed according to our previously described
protocols [26]. Cells were then stimulated with anti-human CD3
and CD28 (both 1 mg/ml) or HBV core antigen (5 mg/ml) in the
presence of human rIL1b, rIL6 and rIL23 (each eBioscience;
10 ng/ml) in a 24-well plate. On day 6, the cells were re-
stimulated with phorbol 12-myristate 13-acetate (PMA, Sigma-
Aldrich; 300 ng/ml) and ionomycin (Sigma-Aldrich; 1 mg/ml) for
5 h in the presence of monensin. Cells were then stained with
APC-conjugated anti-human CD3 and PerCP-conjugated anti-
human CD8, and further permeabilized and stained with
intracellular antibody PE-conjugated anti-human IL-17 [6].
Immunohistochemistry
Paraffin-embedded, formalin-fixed liver tissue (5 mm) was
incubated with anti-CD68 (a marker for monocyes and macro-
phage) or anti-myeloperoxidase (MPO, specific for neutrophils)
antibody overnight at 4uC after blocking endogenous peroxidase
activity with 0.3% H2O2. 3-amino-9-ethyl-carbazole (red color)
was used as the substrate followed by counterstaining with
hematoxylin for single staining according to previously described
protocols [5–7].
Serum HBV DNA assays
The serum HBV DNA assays was performed according to our
recent description [5–7,26]. The cut-off value was 100 IU/ml.
Statistical analysis
All data were analyzed using SPSS version 13.0 for Windows
software (SPSS Inc., Chicago, IL). Comparisons between various
individuals were performed using the Mann-Whitney U test.
Comparison between values within the same individual was
performed using the Wilcoxon matched pairs T test. For all tests,
two-sided P,0.05 was considered to be significant.
Results
Peripheral monocytes and hepatic monocytes/
macrophages are significantly increased in IA patients
We first analyzed the peripheral monocytes in CHB patients
and healthy controls. As shown in Figure 1A, the absolute
numbers of peripheral monocytes were increased in CHB
patients, of whom the IA patients had the highest levels
Figure 1. Increased monocytes in peripheral blood and liver positively correlate with liver injury in IA patients. (A) Absolute counts of
the peripheral blood monocytes from IT (n=32), IA (n=78) patients and healthy controls (n=38). Each dot represents the value from one individual.
P values are shown. (B) The absolute numbers of peripheral blood monocytes was significantly correlated with serum ALT levels but not with HBV
DNA. The solid line represents the linear growth trend and r, the correlative coefficient. P values are shown. (C) Representative immunohistochemical
staining of CD68 in specimens from IA patients. An IA patient with HAI G2S2 scores has higher CD68
+ cell density in liver, compared to that of a
patient with HAI G1S1 scores. (D) Numbers of CD68
+ cells in portal area are shown in IA patients with various degrees of liver HAI scores. Horizontal
bars represent the median CD68
+ cells. ALT, alanine aminotransferase; HAI, histological activity index; IT, Immune tolerant carriers; IA, immune
activated patients.
doi:10.1371/journal.pone.0017484.g001
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0.4660.11 and 0.4060.14; 10
9/ L ;f o rI A ,I Tp a t i e n t sa n d
healthy controls).
Next, we analyzed the correlations between the absolute
number of monocytes and serum ALT levels and plasma HBV
DNA load in these IA patients. A significant positive correlation
was observed between monocyte number and serum ALT levels
(r=0.284, P=0.014), but no correlation was observed between
monocyte numbers and serum HBV DNA loads (r=0.140,
P=0.234; Figure 1B) in these IA subjects. We next examined
the distribution of CD68
+ cells in the livers of CHB patients. As
shown in Figure 1C, an IA patient with HAI G2S2 that had a
higher CD68
+ cell density in the liver than did a patient with HAI
G1S1. Because CD68 molecule was widely expressed on Kupffer
cells in lobular area, the number of CD68
+ cells in portal area was
defined as the macrophages for quantitative analysis. We found
Figure 2. Peripheral CD16
+ monocyte frequencies are significantly increased in IA patients. (A) Monocyte subsets in whole blood were
identified based on forward and side scatter (left panel) and CD14/CD16 expression patterns (right panel). Monocytes were further divided into the
CD14
highCD16
2 subset and a major CD16
+subsets; the latter were further divided into CD14
highCD16
+ and CD14
lowCD16
+ subsets for analysis. (B)
Representative dot plots of three monocyte subsets in IT, IA patients and healthy controls. Values in the quadrants indicate the proportions of
monocyte subsets. (C) Individual values of the three monocyte subsets in IT, IA patients and healthy controls. P values are shown. Horizontal bars
represent the median proportions of each monocyte subset. (D) Individual values of major CD16
+ monocyte subsets in IT, IA patients and healthy
controls. P values are shown. Horizontal bars represent the median proportions of the CD16
+ monocyte subsets. IT, Immune tolerant carriers; IA,
immune activated patients.
doi:10.1371/journal.pone.0017484.g002
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+ cells in the portal area were markedly
accumulated in livers of CHB patients with high HAI scores
(Figure 1D).
Pro-inflammatory CD16
+ monocytes are significantly
increased in peripheral blood of IA patients
Monocytes are generally categorized into the CD14
high CD16
2
subset and the major CD16
+ subsets, the latter being further
divided into CD14
highCD16
+ and CD14
lowCD16
+ subsets
(Figure 2A). As shown in Figure 2B, all subjects clearly displayed
3 subsets of peripheral blood monocytes. Notably, the distribution
of these subsets in HBV-infected subjects differed from that of HC
subjects.
IA patients exhibited a decreased percentage of the CD14
high
CD16
2 monocyte subset and increased percentage of CD14
high
CD16
+ monocytes as compared to HC and IT patients (P,0.05,
Figure 2C). By contrast, there were no significant differences in the
three monocytes subsets between IT patients and HC subjects. A
slight increase in the frequency of the CD14
low CD16
+ monocytes
was observed in IA patients versus HC subjects (P,0.05). Thus, as
shown in Figure 2D, the proportion of CD16
+ monocytes were
significantly increased in the peripheral blood of IA patients.
Figure 3. Increased CD16
+ monocytes in peripheral blood and liver positively correlate with liver injury in IA patients. (A) The major
CD16
+ monocytes and CD14
highCD16
+ monocyte subsets were significantly correlelated with serum ALT levels, but not with HBV DNA. The solid line
represents the linear growth trend and r, the correlative coefficient. P values are shown. (B) Representative dot plots of CD14 and CD16 staining in
monocytes from peripheral blood and LILs isolated from the the same IA patient are shown. Values in the upper-left and upper-right quadrants
represent the percentages of CD14
highCD16
2 monocytes and CD16
+ monocytes, respectively. (C) Individual percentages of hepatic and peripheral
monocytes that express CD16 from the IA patients. Each dot represents one individual. P values are shown. (D) IA patients with higher HAI scores (G
and S) have a higher percentage of monocytes expressing CD16 in their livers, compared to patients with lower HAI scores. P values are shown. ALT,
alanine aminotransferase; HAI, histological activity index; LILs, intrahepatic leukocytes.
doi:10.1371/journal.pone.0017484.g003
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+ monocytes in
peripheral blood and CD16
+ macrophages in liver
positively correlate with liver inflammatory damage in IA
patients
We next analyzed the correlation between the percentage of
monocyte subsets and serum ALT and plasma HBV DNA loads in
these IA patients (Figure 3A). There was a significant positive
correlation between CD16
+monocytes frequency and serum ALT
levels (r=0.617, P,0.001), but no correlation with serum HBV
DNA load in IA subjects was observed. Interestingly, we observed
some significant positive correlations between CD14
high
CD16
+monocytes frequency and serum ALT levels (r=0.826,
P,0.001) and a negative correlation with serum HBV DNA load
(r=0.243, P=0.031) in IA subjects. In contrast, no correlations
were found between CD14
lowCD16
+monocytes and these clinical
markers.
We further dissected the populations of liver-infiltrating
macrophages in LILs from IA patients. Figure 3B shows that
these liver-derived macrophages had increased expression of
CD16 and that these CD16
+ macrophages are present at
significantly increased numbers in LILs compared with peripheral
blood (Figure 3C). We found that CHB patients with high HAI
grading (G2–G4) (n=11) had a greater proportion of CD16
+
macrophages than did CHB patients with low HAI grading (G1,
n=9). Strikingly, we also found that CHB patients with high HAI
staging (S2–S4) (n=8) had a greater proportion of CD16
+
macrophages than did CHB patients with low HAI scores (S1,
n=12) (Figure 3D).
These data suggest that the frequency of peripheral CD16
+
monocytes is closely associated with liver injury as indicated by the
correlation with ALT levels and that the expression of CD16 on
liver macrophages is associated with liver injury as indicated by the
correlation with HAI scores in IA patients.
Activated pro-inflammatory CD16
+ monocytes induce
Th17 cell proliferation
The production of IL-17 by human Th17 cells depends on the
activation status and the anatomical location of monocytes [19–
21]. We then identified the phenotypic features of liver-derived
monocytes by using flow cytometry. The results showed that the
liver-derived monocytes expressed higher levels of HLA-DR
compared with that from peripheral blood indicated by mean
fluorescence intensities (MFI) (Figure 4A). Notably, liver-derived
CD16
+ monocytes exhibited higher levels of HLA-DR compared
with its counterpart in peripheral blood (Figure 4B). Further
analysis showed that CD16
+ monocytes in liver from CHB
patients with high HAI grading (G2-G4, solid dot, HLA-DR
MFI: 692.796268.05) seemed to have slightly increased MFI
values of HLA-DR compared with CHB patients with low
HAI grading (G1, open dot, HLA-DR MFI: 528.446135.14,
P=0.049).
Monocytes from CHB patients secreted increased cytokines,
including IL-1b, IL-6, IL-23, and TNF, which have been shown to
regulate the development of Th17 cells [19–21]. We first
examined the production of these pro-inflammatory cytokines in
subsets of monocytes under LPS stimulation in vitro. As shown in
Figure 4C, monocytes produced large quantities of these cytokines,
and there was no difference in the frequencies of cytokine-
producing monocytes within the monocyte subsets in the
peripheral blood. However, CD16
+ monocytes seemed to have
increased secretion of TNF, IL-6, IL-1b and IL-12/IL-23 p40
than did CD14
highCD16
2 monocytes, indicated by mean
fluorescence intensities (MFI) of the labeled cells in these CHB
patients (Figure 4D).
TNF is one of the final mediators of destructive activity on
hepatic cells, but blockade of TNF has no effect on the expansion
of Th17 cells [26]. In this section, we investigated the response of
Th17 cells under TCR-stimulation (anti-CD3/CD28 or HBV
antigen) together with exogenously added IL-1b, IL-6 and IL-23
to mimic the inflammatory environment in the livers of CHB
patients. The ratios of the numbers of IL-17-producing cells and
proliferating CFSE
low Th17 cells compared to those in the absence
of the cytokine cocktail (considered as 1) was calculated for each
response, and the fold changes are shown in Figure 4E–4F. We
found that TCR-stimulation alone triggered only a low level of
Th17 cell proliferation, whereas the addition of the cytokine
cocktail, along with TCR-stimulation, profoundly induced prolif-
eration of Th17 cells and the accumulation of CFSE
low Th17 cells
among these CD4 T cells. In addition, an increased percentage of
IL-17
+ cells were found when purified CD4
+ T cells were
stimulated in the presence of LPS-activated CD16
+ monocytes
(Figure 4G).
Neutrophils are reduced in peripheral blood, but
accumulated in the livers of in IA patients
We observed that neutrophils in the peripheral blood from
CHB patients were significantly decreased compared with those of
healthy controls, and they correlated with disease stage in CHB
patients. As shown in Figure 5A, a significant decrease of absolute
numbers of neutrophils was shown in IA patients versus IT
patients and healthy controls (2.5160.77, 2.9760.82 versus
3.4261.19; 10
9/L).
Next, we analyzed the correlations between absolute numbers of
neutrophils and serum ALT levels and plasma HBV DNA load in
these IA patients. The number of neutrophils were signifi-
cantly positively correlated with serum ALT levels (r=20.267,
P=0.021), but not with serum HBV DNA load (r=0.043,
P=0.719; Figure 5B) in these IA subjects. Strikingly, more
MPO
+ cells were found to be infiltrated in the livers of patients
Figure 4. Hyper-activated CD16
+ monocytes preferentially produce Th17-related cytokines. (A) Histogram plots of HLA-DR expression on
monocytes and CD16
+ monocytes from circulating monocytes (blood) and liver-infiltrating monocytes (liver) in a representative IA individual. (B) The
MFI values of HLA-DR expressed on monocytes and CD16
+ monocytes from CHB patients in each group. Each open dot represents one subject with
lower HAI scores and each solid dot represents patients with higher HAI scores. (C) Representative histogram plots of TNF-a, IL-6, IL-1b, IL-12/23 p40
expression (red line histograms) or isotype control (green line histograms) on CD14
+ CD16
2 monocytes and CD16
+ monocytes in an IA subject. (D)
Data shown are representative of ten independently performed experiments from IA subjects. (E) Representative expansion of Th17 cells with the
cytokine cocktail (IL-6, IL-1b and IL-23) and TCR-stimulation. Values in the upper left quadrant indicate the percentages of CFSE
low Th17 cells. (F)
Individual values of the fold changes in the percentage of total and CFSE
low Th17 cells. Horizontal bars indicate the median fold changes. (G)
Representative expansion of Th17 cells with activated CD16
+ monocytes in HC subjects (n=4). Purified CD4
+ T cells from HCs were cocultured with
autologous CD16
+ monocytes and anti-CD3/CD28 microbeads in the absence or presence of LPS. After 4 days, cells were stimulated for 6 h with
PMA/ionomycin and Golgi-stop (during the last 5 h), and IL-17 expression and production were determined by ICC staining. Values in the upper
quadrant represent the percentage of Th17 cells. MFI, mean fluorescence intensity; HAI, histological activity index; IA, immune activated patients;
CFSE, Carboxyfluorescein succinimidyl ester.
doi:10.1371/journal.pone.0017484.g004
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results were also obtained when we measured the percentages of
neutrophils in LILs (Figure 5C) which progressively increased in
patients with HAI scores: more neutrophils infiltrated the livers of
patients with higher G and S scores (Figure 5D).
Discussion
Non-HBV-specific infiltration of inflammatory cells into the
liver is likely responsible for liver pathology during chronic
HBV infection in humans; however, very little information
available is known about the compartmentalization of cell types
within the affected liver, let alone about the crosstalk among
these cells. Here, we for the first time assessed the quantities,
percentages and cytokine profiles of peripheral and intrahepatic
monocyte/macrophage subsets in CHB patients and document-
ed a significant increase in peripheral monocytes and intrahe-
patic macrophages as well as CD16
+ subsets, which were closely
associated with the liver inflammation. Moreover, these
increased CD16
+ monocytes preferentially released inflamma-
tory cytokines, a process likely involved in the induction of liver
damage and expansion of Th17 cells. Furthermore, the
accumulated hepatic neutrophils were associated with liver
injury. These distinct properties of monocyte/macrophage
subpopulations as well as highly pathogenic neutrophils may
further represent a collaborative scenario among different types
of cells leading to the pathogenesis of HBV-induced liver
disease.
Figure 5. Increased neutrophils in liver in situ positively correlate with liver injury in IA patients. (A) Absolute counts of peripheral blood
neutrophils from IT (n=32), IA (n=78) patients and healthy controls (n=38). Each dot represents one individual. P values are shown. (B) The absolute
number of neutrophils significantly negatively correlated with the serum ALT levels, but not with HBV DNA. The solid line represents the linear
growth trend and r, the correlative coefficient. P values are shown. (C) Immunohistochemical staining for MPO (specific for neutrophils) in the portal
area in IA patients with HAI scores (G1S1 and G2S2) (4006). A G2S2 patient had a higher percentage of neutrophils in LILs compared to a G1S1
patient. Values in the upper right indicate the percentages of neutrophils in LILs. (D) IA patients with higher HAI scores (G and S) have a higher
percentage of liver neutrophils in the portal area, compared to patients with lower HAI scores. Each dot represents one individual. P values are
shown. Horizontal bars represent the median proportions of liver neutrophils. IT, Immune tolerant carriers; IA, immune activated patients. HAI,
histological activity index; LILs, intrahepatic leukocytes.
doi:10.1371/journal.pone.0017484.g005
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however, to our knowledge, different monocyte subsets from
peripheral blood and liver have not been previously associated
liver damage in CHB patients. As such, we first characterized
absolute numbers of monocytes in a cohort of CHB patients, and
found that the monocytes were increased in peripheral blood of IA
over IT patients. This finding was further supported by the
observation of more intrahepatic monocytes in IA patients. The
present study demonstrated that the increased CD16
+ pro-
inflammatory subset of monocytes in CHB patients is associated
with liver injury. There are three observations to support this
notion.First,theCD16
+subsetfrequenciesinperipheralbloodwere
positively correlated with serum ALT levels in IA patients. Notably,
the increased CD16
+ subset frequencies were mainly due to an
increased in the absolute number of these cells. In addition, patients
with higher HAI scores had more CD16
+ monocytes/macrophages
in the liver in situ than did patients with lower HAI scores from
analysis of the liver biopsies. In combination with previous report in
chronic inflammatory liver disease that CD16
+ monocytes were
recruited by a combination of adhesive signals involving VAP-1 and
CX3CR1-mediated integrin-activation and localized in areas of
active inflammation and fibrosis in livers [28], these data support
the concept that CD16
+ monocytes/macrophages in IA patients
play an important role in liver damage and fibrosis. Third,
monocytes produced high levels of TNF, which are a major
cytokine involved in several types of liver damage. Furthermore, the
CD16
+ subset of monocytes not only produced high levels of TNF,
but also secreted a large amount of IL-6, IL-1b and IL-12/IL-23
P40. These pro-inflammatory cytokines which are critical for the
process of liver damage during hepatitis B progression are also
responsible for the differentiation of Th17 cells. All together, these
data indicate that the CD16
+ subset of monocytes may be closely
related to liver damage in these IA patients.
Recent studies have demonstrated that activated monocytes/
macrophages isolated from the site of inflammation may induce
Th17 responses [19–21]. The present study further indicated
monocytes/macrophages in LILs exhibited higher HLA-DR
expression than peripheral monocytes. Furthermore, the CD16
+
subset in LILs expressed higher levels of HLA-DR than those in
the periphery. These findings indicated that monocytes with its
subsets are highly activated under the inflammatory microenvi-
ronment in the liver. Indeed, our previous studies indicated that
increased multiple pro-inflammatory cytokines, including IL-6, IL-
1b and IL-12/IL-23 in the peripheral blood and liver, are present
in CHB patients [6,27]. Furthermore, increased IL-17 can directly
affect monocytes and mDCs infiltrated into the liver, thereby
exacerbating the inflammatory microenvironment of the liver.
This cytokine milieu in the liver, including IL-1b, IL-6 and IL-23,
may regulate the differentiation and expansion of human Th17
cells. Interestingly, we found that HBcAg can induce a profound
effect on Th17 cells proliferation in the presence of these pro-
inflammatory cytokines. These preliminary data indicated that the
microenvironment in inflammatory liver, at least in part, may
contribute to the differentiation and expansion of Th17 cells in
these patients.
The present observations of the neutrophils were absolutely in
line with the available literature on neutrophil biology in a mouse
model of cholestatic liver damage [29,30] and further indicated
that the accumulated neutrophils in liver, as well as the decreased
numbers of neutrophils in peripheral blood, are associated with
liver injury in CHB patients. In addition, Th17 cells were shown to
activate the IL-17 receptor-expressing cells in the liver, while the
latter recruited neutrophils through IL-8 and growth related
oncogen a secretion in alcoholic liver disease [23]. Furthermore,
IL-8 levels in livers of CHB patients are increased [4]. Together
with these findings, our study suggested that the accumulated
Th17 cells in the liver, at least in part, may attract neutrophils.
Future studies should investigate the mechanisms that govern
neutrophil-induced liver damage in CHB patients.
Taken together, our data demonstrated, for the first time, that
monocytes as well as pro-inflammatory CD16
+monocytes and
neutrophils participate in the modulation of inflammatory
response and liver damage in CHB patients, and provide insight
into the effect of these highly pathogenic cells on Th17 cells. These
findings further demonstrate that targeting of inflammatory
monocytes could lead not only to a decrease in the production
of pro-inflammatory cytokines and Th17 cells, but also to the
disruption of the cycle of inflammation due to induction and
expansion of these cells.
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